Navigation Links
Research on improvements in diagnosing and treating tuberculosis
Date:6/19/2012

y. Among infectious diseases, this is the main cause of death among young adults in developing countries, particularly among the poorest ones. It is estimated that there are five million new cases every year throughout the world and that the possibility of being cured is only 60%. The efficacy of programs to fight tuberculosis continues to be burdened by the need to keep patients in treatment for 6 to 24 months. Financing and support for trials are limited.

With its participation in this project, UC3M has joined large-scale research in the area of health science. The project, which began in May of this year and is expected to last for sixty months, is being led by the pharmaceutical company GlaxoSmithKline and includes 21 prestigious international partners. The partners who come from private industry are: GlaxoSmithKline, Sanofi-Aventis, Janssen, Microsense Medtech and ZF Screens. Partners from the academic world are: the University of Liverpool, UC3M, Max Plank Institute, Erasmus University, Health Protection Agency UK, Institut Pasteur, St Georges University London, University of St Andrews, EPFL, Univ. of Leicester, University College of London, VU University, the Liverpool School of Tropical Medicine and Uppsala University.


'/>"/>
Contact: Ana Herrera
oic@uc3m.es
Carlos III University of Madrid
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Grant program to spur new research on Alzheimers disease by encouraging collaboration
2. Research breakthrough: High brain integration underlies winning performances
3. IOC recognizes University of Calgary Sports Injury Research Prevention Centre
4. Scripps Research Institute announces five-year research collaboration with Bristol-Myers Squibb
5. Researchers identify need to sample multiple tumor zones in breast cancer
6. London researchers discover novel mechanism involved in key immune response
7. NTU researchers study little mighty creature for scientific breakthrough
8. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
9. UTMB researchers create powerful new method to analyze genetic data
10. Astellas and DNDi to collaborate on new drug discovery research for the treatment of NTDs
11. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research on improvements in diagnosing and treating tuberculosis
(Date:12/17/2014)... The Defense Logistics Agency is insourcing its efforts ... microcircuits from entering into its supply chain. ... initiative dubbed DNA marking. The capability will validate the ... the supply chain. The new quality control measures will ...
(Date:12/17/2014)... Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has announced the ... report to their offering. ... in this market is the increasing demand for medical ... of patient data for quick and correct diagnosis during ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... 2015-2019"  report to their offering. One ... technology. With continuous advances in technology, it is important ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... physicians, researchers and academics from around the world ... for Digestive Disease Week (DDW), the premiere scientific ... and gastrointestinal surgery. Each day of ... on a broad variety of gastrointestinal health issues: ...
... it doesn,t look much different than its kin at the ... deceiving. This one, a Lovell variety, has a unique genetic ... DNA its genetic set of instructions for living ... beneficial traits to grow better trees and fruit. The ...
... have developed two advanced broadband acoustic systems that they ... from black-and-white television to high-definition color TV. For oceanographers, ... to count and classify fish and to pinpoint tiny ... Stanton and Andone Lavery in the Department of Applied ...
Cached Biology News:Latest research on GI health presented at DDW 2010 2Researchers sequence DNA of peach tree at Clemson University 2Researchers sequence DNA of peach tree at Clemson University 3Now in broadband: Acoustic imaging of the ocean 2Now in broadband: Acoustic imaging of the ocean 3Now in broadband: Acoustic imaging of the ocean 4Now in broadband: Acoustic imaging of the ocean 5
(Date:1/22/2015)... BOSTON , Jan. 22, 2015  Transwestern | RBJ today ... feet of office space for Shire a leading biopharmaceutical company, ... . Transwestern | RBJ,s Robert Richards , president, and ... the lease for the entire five-floor building at 95 Hayden ...
(Date:1/22/2015)... laboratory information management systems market is a rapidly growing ... due to factors such as rising pressure to comply ... and increasing government support for adoption of HCIT solutions ... the market focus on technological advancements to further the ...
(Date:1/22/2015)... zFlo Motion , a US leader in biomechanics ... from a new partner. STT-Systems has developed an ... years, with offerings in the optical-motion capture, 3D scanning, and ... measurement unit), iSen, is opening eyes around the world. With ...
(Date:1/22/2015)... 2015 Diagenode, Inc., a leading ... Bioruptor® and complete solutions for epigenetics research, recently ... alleviating the need for manual processing. The new ... ChIP of histones or transcription factors and a ...
Breaking Biology Technology:Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... Calif., Aug. 30 ThermoGenesis Corp. (Nasdaq: KOOLD ... process and store adult stem cells, said today it has ... HealthBanks, which operates cord blood banks in Taiwan, ... of 20 BioArchives and a storage capacity for cryopreserving and ...
... Dr. Kyong S. Choe, of Kwangju, South Korea, has been ... outstanding contributions and achievements in the field of healthcare. ... Dr. Choe is currently practicing with Feldman, Fitzgerald ... periodontics and prosthodontics targeting implants and full prosthetic reconstruction.  He ...
... <meta name="description" content="Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange. - ... Amex Beginning Monday, September 6, 2010 under the Ticker Symbol PLX -,- Company ... 10, 2010." /> Protalix BioTherapeutics to Dual List on Tel Aviv ... ...
Cached Biology Technology:ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market 2ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market 3Dr. Kyong S. Choe Recognized by Strathmore's Who's Who Worldwide Publication 2Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 2Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 3Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 4Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 5Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 6Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 7Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange 8
... low background ,This solution greatly enhances antigen-antibody ... than obtained with conventional methods. ,Two kinds ... secondary antibodies, which can suppress the background ... Wide versatility ,It is applicable to various ...
Mouse Anti-Human Killer Cell Immunoglobulin-like Receptor, Two Domains, Long Cytoplasmic Tail, 2 (KIR2DL2 (KIR2DL3 Monoclonal Antibody Family: Immunoglobulin Sub-Family: not assigned-Immunogl...
pH-dependent fluorescence; Maximum intensity observed in basic solutions....
Mouse anti human pro-Relaxin-2...
Biology Products: